Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules
The present review focuses on recent clinical trials that analyze the efficacy of
intravitreal therapeutic agents for the treatment of dry age-related macular degeneration (AMD),
such as neuroprotective drugs, and complement inhibitors, also called immunomodulatory or
anti-inflammatory agents. A systematic literature search was performed to identify randomized
controlled trials published prior to January 2019. Patients affected by dry AMD treated with
intravitreal therapeutic agents were included. Changes in the correct visual acuity and reduction in